Cellectis (NASDAQ:CLLS) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Cellectis (NASDAQ:CLLS – Get Free Report) in a report issued on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock. Separately, Barclays reduced their price objective on Cellectis from $7.00 to $5.00 and set an “overweight” rating for the company in a report on Tuesday, November […]
More Stories
General Mills (NYSE:GIS) Sets New 12-Month Low – Time to Sell?
General Mills, Inc. (NYSE:GIS – Get Free Report)’s stock price reached a new 52-week low on Monday . The company...
Jubilee Metals Group (LON:JLP) Hits New 1-Year Low – Here’s Why
Shares of Jubilee Metals Group PLC (LON:JLP – Get Free Report) reached a new 52-week low on Monday . The...
Identillect Technologies (CVE:ID) Shares Down 50% – Should You Sell?
Identillect Technologies Corp. (CVE:ID – Get Free Report) shares fell 50% on Monday . The company traded as low as...
Primoris Services Corporation Promotes Jeremy Kinch to Chief Operations Support OfficerDallas, TX – January 7, 2025 – Primoris Services Corporation (NYSE: PRIM) announced on January 7, 2025, the promotion of Jeremy Kinch to the position of Chief Oper
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Magna Terra Minerals (CVE:MTT) Trading Down 18.2% – Here’s Why
Magna Terra Minerals Inc. (CVE:MTT – Get Free Report) was down 18.2% during trading on Monday . The company traded...
KushCo (OTCMKTS:KSHB) Shares Up 0.1% – Should You Buy?
KushCo Holdings, Inc. (OTCMKTS:KSHB – Get Free Report) was up 0.1% on Wednesday . The stock traded as high as...